Cancer stem cell antigen vaccines and methods
US9023338B2 · kind B2 · utility
3Cited by
46References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 3, 2012 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | Jan 31, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of stimulating an immune response (e.g., to treat cancer) include administering to a patient a composition including dendritic cells that present cancer stem cell antigens. Compositions including cancer stem cell antigens are also provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.